Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07095673 · ClinicalTrials.gov registry record · NA

HealthyWE: Achieving a Healthy Weight and Reducing Pain

A NA study of Obesity & Overweight, sponsored by Rutgers, The State University of New Jersey.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT07095673: Recruiting NA study of Obesity & Overweight, sponsored by Rutgers, The State University of New Jersey.

NCT07095673 is a NA study of Obesity & Overweight that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 80 participants, below the 112-participant average among 28 other Obesity & Overweight trials with a reported enrollment target (29% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07095673, a NA study of Obesity & Overweight, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The goal of this project was to reduce and manage obesity and increase self-efficacy for keeping a healthy weight and improve pain, quality of life, and mental health symptoms among 60 adults aged 19 and older in Camden City, New Jersey. The City of Camden has an adult obesity rate of 44.1%. Obesity and aging are significant contributing factors to increased utilizations of healthcare services. Obesity is a major risk factor for non-communicable illnesses such as cardiovascular disease, type 2 diabetes, hypertension, dyslipidemia, pain, and mental health. Physical activity is effective in reducing and managing obesity. However, personal barriers (e.g., lack of time for physical activity, physical capability to perform physical activities, competing demands), built environment (e.g., safe spaces for physical activities), climate changes (e.g., heat waves and extreme weather which prevent outdoor physical activities), and systematic barriers (e.g., intervention availability) hamper obesity prevention and management in older adult population. To help older adults keep a healthy weight, our team has adapted and delivered the effective person-centered integrative interventions: HealthyWE: Keeping a Healthy Weight program to older adults in Camden New Jersey. Completion of the project will build a strong community capacity in Camden to sustain a community effort to reduce obesity and pain.

Primary Outcome

A stand-on bioimpedance analysis (BIA) device (InBody 520, Biospace Co., Ltd., Cerritos, CA, USA) is used to automatically calculate BMI (kilogram/meters squared, kg/m2). Obesity is defined as a BMI\>30 kg/m2. The Inbody 520 multifrequency BIA device is also used to measure body fat percentage, and body fat mass using impedance at 5, 50, and 500 kHz.

Conditions Studied

Interventions

  • BEHAVIORAL HealthyWE

Study Locations (1)

New Jersey

  • School of Nursing Camden - Camden

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2023-06-20
Est. Completion 2026-09-30
Phase NA

What NCT07095673 shows while recruiting

NCT07095673 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 112-participant average among 28 other Obesity & Overweight trials with a reported enrollment target (29% lower).

The record links to 1 condition, with Obesity & Overweight appearing as the primary indexed condition, and to 1 intervention - of which HealthyWE is the first listed.

NCT07095673 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT07095673 about?

NCT07095673 is a clinical study titled "HealthyWE: Achieving a Healthy Weight and Reducing Pain". The goal of this project was to reduce and manage obesity and increase self-efficacy for keeping a healthy weight and improve pain, quality of life, and mental health symptoms among 60 adults aged 19 and older in Camden City, New Jersey. The City of Camden has an adult obesity rate of 44.1%. Obesity...

What is the current status of trial NCT07095673?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-06-20. Estimated completion is 2026-09-30.

What conditions does trial NCT07095673 study?

This clinical trial studies the following conditions: Obesity & Overweight.

What interventions are being tested in trial NCT07095673?

The interventions under investigation include: HealthyWE (BEHAVIORAL).

Who is sponsoring clinical trial NCT07095673?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07095673 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity & Overweight

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07095673's enrollment target sits among peer trials

80 14th of 28 higher than 13 of 28 other Obesity & Overweight trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity & Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07095673, the US trial registry maintained by the National Library of Medicine. NCT07095673 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.